Supplement. Sample reports

From Cancer Guidelines Wiki


Sample cervical screening reports

CERVICAL SCREENING LOW RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Cervical – ThinPrep
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Not detected
RECOMMENDATION Rescreen in five years.

CERVICAL SCREENING UNSATISFACTORY
SPECIMEN Cervical – SurePath
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype: Unsatisfactory
RECOMMENDATION Retest within six weeks.

CERVICAL SCREENING UNSATISFACTORY
SPECIMEN Cervical – ThinPrep
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.), Image assisted:
Unsatisfactory

RECOMMENDATION Repeat screening test in six weeks.

CERVICAL SCREENING INTERMEDIATE RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Cervical – SurePath
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.), Manually Read:
There is no evidence of a squamous intraepithelial lesion or malignancy
Endocervical component: Present

RECOMMENDATION Repeat test in 12 months.

CERVICAL SCREENING INTERMEDIATE RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Cervical – SurePath
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.), Image Assisted:
Low grade intra-epithelial lesion (LSILLow-grade squamous intraepithelial lesionThe low-grade squamous intraepithelial lesion (LSIL) category is the morphological correlate of productive viral infection. It is to be used when the scientist/pathologist observes changes that would have been described as ‘HPV effect’ or ‘CIN 1’ in the previous Australian terminology and represents part of the previous ‘low-grade squamous epithelial abnormality’ category.)
Endocervical component: Present

RECOMMENDATION Repeat test in 12 months.

CERVICAL SCREENING HIGHER RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Cervical – ThinPrep
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Not detected
  • HPV 18 – Detected
  • HPV (not 16/18) – Not detected

Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.), Manually Read:
High grade squamous intra-epithelial lesion (HSILHigh-grade squamous intraepithelial lesionIn the Australian context, HSIL is used to refer to a cytology predictive of a high grade precancerous lesion (AMBS 2004), or histologically confirmed high grade precancerous lesion (HSIL-CIN2 or HSIL-CIN3 as per LAST terminology).)
Endocervical component: Present

RECOMMENDATION Referral for Colposcopic assessment.

CERVICAL SCREENING HIGHER RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Cervical – SurePath
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Not detected

Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.), Manually Read:
Unsatisfactory

RECOMMENDATION Referral for Colposcopic assessment.

CERVICAL SCREENING HIGHER RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Cervical – ThinPrep
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.), Image Assisted:
Possible high grade squamous intra-epithelial lesion (pHSILPossible HSIL in the Australian Modified Bethesda System is broadly equivalent to ASC-H in US Bethesda system.)
Endocervical component: Not identified

RECOMMENDATION Referral for Colposcopic assessment.

CERVICAL SCREENING HIGHER RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Cervical – SurePath
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.), Manually Read:
High grade squamous intra-epithelial lesion (HSILHigh-grade squamous intraepithelial lesionIn the Australian context, HSIL is used to refer to a cytology predictive of a high grade precancerous lesion (AMBS 2004), or histologically confirmed high grade precancerous lesion (HSIL-CIN2 or HSIL-CIN3 as per LAST terminology).)
Endocervical component: Not identified

RECOMMENDATION Referral for Colposcopic assessment.

CERVICAL SCREENING HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Cervical – ThinPrep
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Not detected

Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.), Image Assisted:
There is no evidence of a squamous intraepithelial lesion or malignancy
Endocervical component: Present

RECOMMENDATION Referral for Colposcopic assessment.

CERVICAL SCREENING HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Cervical – SurePath
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.), Manually Read:
There is no evidence of a squamous intraepithelial lesion or malignancy
Endocervical component: Present

RECOMMENDATION In view of the previously reported abnormality referral for colposcopic assessment.

CERVICAL SCREENING HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Cervical – ThinPrep
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.), Image Assisted:
Low grade squamous intra-epithelial lesion (LSILLow-grade squamous intraepithelial lesionThe low-grade squamous intraepithelial lesion (LSIL) category is the morphological correlate of productive viral infection. It is to be used when the scientist/pathologist observes changes that would have been described as ‘HPV effect’ or ‘CIN 1’ in the previous Australian terminology and represents part of the previous ‘low-grade squamous epithelial abnormality’ category.)
Endocervical component: Present

RECOMMENDATION In view of the previously reported abnormality referral for colposcopic assessment.

CERVICAL SCREENING HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Cervical – SurePath
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.), Manually Read:
Atypical endocervical cells of undetermined significance
There is no evidence of a squamous intraepithelial lesion or malignancy

RECOMMENDATION Referral for colposcopic assessment by a gynaecologist with expertise in the evaluation of suspected malignancies or by a gynaecological oncologist.

CERVICAL SCREENING HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Cervical – ThinPrep
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Not detected
  • HPV 18 – Detected
  • HPV (not 16/18) – Not detected

Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.), Image Assisted:
Possible high grade glandular lesion
The findings suggest possible adenocarcinoma-in-situ

RECOMMENDATION Referral for colposcopic assessment by a gynaecologist with expertise in the evaluation of suspected malignancies or by a gynaecological oncologist.

CERVICAL SCREENING HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Cervical – ThinPrep
TEST RESULTS PCRPolymerase Chain Reaction for High Risk HPV and genotype:
  • HPV 16 – Detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Not detected

Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.) Image Assisted:
Squamous cell carcinoma
There are abnormal cells that indicate origin from an invasive squamous cell carcinoma Endocervical component: Present

RECOMMENDATION ColposcopyThe examination of the cervix and vagina with a magnifying instrument called a colposcope, to check for abnormalities. is recommended. Patient should be referred to a gynaecological oncologist or a gynaecological cancer centre for assessment.

CERVICAL SCREENING HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Cervical – SurePath
TEST RESULTS PCRPolymerase Chain Reaction for High Risk HPV and genotype:
  • HPV 16 – Not detected
  • HPV 18 – Detected
  • HPV (not 16/18) – Not detected

Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.), Manually Read:
Endocervical adenocarcinoma

RECOMMENDATION ColposcopyThe examination of the cervix and vagina with a magnifying instrument called a colposcope, to check for abnormalities. is recommended. Patient should be referred to a gynaecological oncologist or a gynaecological cancer centre for assessment.

Sample stand alone LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory. reports

SPECIMEN Cervical – SurePath
TEST RESULTS Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.) Manually Read:


Low grade squamous intra-epithelial lesion (LSILLow-grade squamous intraepithelial lesionThe low-grade squamous intraepithelial lesion (LSIL) category is the morphological correlate of productive viral infection. It is to be used when the scientist/pathologist observes changes that would have been described as ‘HPV effect’ or ‘CIN 1’ in the previous Australian terminology and represents part of the previous ‘low-grade squamous epithelial abnormality’ category.)
Endocervical component: Present

RECOMMENDATION This woman is under specialist management, therefore no management recommendation is made.

SPECIMEN Cervical – ThinPrep
TEST RESULTS Liquid Based Cytology (LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory.) Image assisted:


High grade squamous intra-epithelial lesion (HSILHigh-grade squamous intraepithelial lesionIn the Australian context, HSIL is used to refer to a cytology predictive of a high grade precancerous lesion (AMBS 2004), or histologically confirmed high grade precancerous lesion (HSIL-CIN2 or HSIL-CIN3 as per LAST terminology).)
Endocervical component: Present

RECOMMENDATION This woman is under specialist management, therefore no management recommendation is made.

Reports for self-collected samples

CERVICAL SCREENING LOW RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Lower vaginal sample – Self collected
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Not detected
RECOMMENDATION Rescreen in five years.

CERVICAL SCREENING
SPECIMEN Lower vaginal sample – Self collected
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected
RECOMMENDATION Collect a cervical sample for LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory. within six weeks.

CERVICAL SCREENING HIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMEN Lower vaginal sample – Self collected
TEST RESULTS PCRPolymerase Chain Reaction for Oncogenic HPV and genotype:
  • HPV 16 – Detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Not detected
RECOMMENDATION Refer for colposcopic assessment. Cervical sample for LBCLiquid based cytology(LBC) is a way of preparing cervical samples for examination in the laboratory. can be obtained at time of that assessment.
Back to top